View open positions at Huntsman Cancer Institute. For further information, please email HCI.recruitment@hci.utah.edu.

View HCI policies and procedures


Tumor Immunologist in Melanoma Research

Huntsman Cancer Institute (HCI) and the Department of Pathology at the University of Utah are seeking a productive, collaborative, and innovative faculty member to join our multidisciplinary team devoted to melanoma. We seek an exceptional investigator with expertise in tumor immunology whose research expertise complements our ongoing areas of excellence in melanoma genetics, pre-clinical models of melanoma in mouse (GEMMs and PDXs) and zebrafish, mechanisms and biomarkers of drug sensitivity/resistance, chemoprevention and clinical trials for melanoma as well as risk assessment and communication.

The successful candidate will be appointed as a full-time Assistant, Associate, or Full Professor of Pathology in the tenure track and as an Investigator at HCI. Qualified individuals must have a PhD, MD, or MD/PhD. For appointment at the Associate or Full Professor level, candidates must have an excellent record of basic, translational, or clinical research achievement in the area of melanoma, including peer-reviewed funding. For appointment at the Assistant Professor level, candidates must have an excellent record of achievement as a trainee and show strong potential for future success in the field. Although we are particularly interested in candidates with a focus on tumor immunology or immune checkpoint-directed therapy, suitably qualified individuals in all areas of melanoma research are strongly encouraged to apply. The successful candidate will be expected to conduct an externally-funded melanoma research program, to participate in weekly treatment planning and research conferences, and engage in collaborative research efforts with members of the HCI Melanoma Disease Center.

HCI is an NCI-designated comprehensive cancer center and a member of the National Comprehensive Cancer Network with two dedicated cancer research buildings and a 100-bed cancer specialty hospital. The Melanoma Disease Center is one of ten Disease Centers supported by HCI that is actively involved in collaborative translational cancer research and clinical trial development. Salary and academic rank are commensurate with experience.

The University of Utah Health (U of U Health) is a patient focused center distinguished by collaboration, excellence, leadership, and respect. The U of U Health values candidates who are committed to fostering and furthering the culture of compassion, collaboration, innovation, accountability, diversity, integrity, quality, and trust that is integral to our mission.

Application deadline: November 30, 2020. To apply go to: http://utah.peopleadmin.com/postings/108175.

For further information, please contact Dr. Martin McMahon, Chair of the Search Committee via the HCI recruitment office at hci.recruitment@hci.utah.edu.

The University of Utah is an Affirmative Action/Equal Opportunity employer and does not discriminate based upon race, national origin, color, religion, sex, age, sexual orientation, gender identity/expression, status as a person with a disability, genetic information, or Protected Veteran status. Individuals from historically underrepresented groups, such as minorities, women, qualified persons with disabilities and protected veterans are encouraged to apply. Veterans’ preference is extended to qualified applicants, upon request and consistent with University policy and Utah state law. Upon request, reasonable accommodations in the application process will be provided to individuals with disabilities. To inquire about the University’s nondiscrimination or affirmative action policies or to request disability accommodation, please contact: Director, Office of Equal Opportunity and Affirmative Action, 201 S. Presidents Circle, Rm 135, (801) 581-8365.

The University of Utah values candidates who have experience working in settings with students from diverse backgrounds, and possess a strong commitment to improving access to higher education for historically underrepresented students.